Ostertag revisited

The inherited systemic amyloidoses without neuropathy

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Mutations in a number of plasma proteins, including transthyretin, apolipoprotein AI, fibrinogen Aα-chain, lysozyme, and apolipoprotein AII, are associated with hereditary systemic amyloidosis. Transthyretin amyloidosis is the most common and is usually associated with peripheral neuropathy. Mutations in the other proteins usually have no neuropathic consequences and, instead, cause principally renal and cardiac amyloidosis. Only the apolipoprotein AI glycine 26 arginine mutation may cause peripheral neuropathy and then in only some of the kindreds with this disease. This review is concerned with the non-neuropathic hereditary systemic amyloidoses. It strives to present a synopsis of the present day knowledge of these diseases including each feature of each precursor protein and its mutations; the clinical phenotype of the disease; and suggestions for treatment when feasible. The main objective is to increase awareness of these autosomal dominant diseases, enhance the chances of early diagnosis, enhance the physician's and subsequently the patient's knowledge of each disease, and finally emphasize the need for more research to find ways to treat or prevent these diseases.

Original languageEnglish
Pages (from-to)75-87
Number of pages13
JournalAmyloid
Volume12
Issue number2
DOIs
StatePublished - Jun 2005

Fingerprint

Amyloidosis
Familial Amyloidosis
Mutation
Apolipoprotein A-I
Peripheral Nervous System Diseases
Apolipoprotein A-II
Prealbumin
Protein Precursors
Muramidase
Glycine
Fibrinogen
Arginine
Blood Proteins
Early Diagnosis
Physicians
Phenotype
Kidney
Research
Proteins

Keywords

  • Amyloid
  • Amyloidosis
  • Familial
  • Hereditary

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Ostertag revisited : The inherited systemic amyloidoses without neuropathy. / Benson, Merrill.

In: Amyloid, Vol. 12, No. 2, 06.2005, p. 75-87.

Research output: Contribution to journalArticle

@article{924363c2366243ff93cd1397450cc64a,
title = "Ostertag revisited: The inherited systemic amyloidoses without neuropathy",
abstract = "Mutations in a number of plasma proteins, including transthyretin, apolipoprotein AI, fibrinogen Aα-chain, lysozyme, and apolipoprotein AII, are associated with hereditary systemic amyloidosis. Transthyretin amyloidosis is the most common and is usually associated with peripheral neuropathy. Mutations in the other proteins usually have no neuropathic consequences and, instead, cause principally renal and cardiac amyloidosis. Only the apolipoprotein AI glycine 26 arginine mutation may cause peripheral neuropathy and then in only some of the kindreds with this disease. This review is concerned with the non-neuropathic hereditary systemic amyloidoses. It strives to present a synopsis of the present day knowledge of these diseases including each feature of each precursor protein and its mutations; the clinical phenotype of the disease; and suggestions for treatment when feasible. The main objective is to increase awareness of these autosomal dominant diseases, enhance the chances of early diagnosis, enhance the physician's and subsequently the patient's knowledge of each disease, and finally emphasize the need for more research to find ways to treat or prevent these diseases.",
keywords = "Amyloid, Amyloidosis, Familial, Hereditary",
author = "Merrill Benson",
year = "2005",
month = "6",
doi = "10.1080/13506120500106925",
language = "English",
volume = "12",
pages = "75--87",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Ostertag revisited

T2 - The inherited systemic amyloidoses without neuropathy

AU - Benson, Merrill

PY - 2005/6

Y1 - 2005/6

N2 - Mutations in a number of plasma proteins, including transthyretin, apolipoprotein AI, fibrinogen Aα-chain, lysozyme, and apolipoprotein AII, are associated with hereditary systemic amyloidosis. Transthyretin amyloidosis is the most common and is usually associated with peripheral neuropathy. Mutations in the other proteins usually have no neuropathic consequences and, instead, cause principally renal and cardiac amyloidosis. Only the apolipoprotein AI glycine 26 arginine mutation may cause peripheral neuropathy and then in only some of the kindreds with this disease. This review is concerned with the non-neuropathic hereditary systemic amyloidoses. It strives to present a synopsis of the present day knowledge of these diseases including each feature of each precursor protein and its mutations; the clinical phenotype of the disease; and suggestions for treatment when feasible. The main objective is to increase awareness of these autosomal dominant diseases, enhance the chances of early diagnosis, enhance the physician's and subsequently the patient's knowledge of each disease, and finally emphasize the need for more research to find ways to treat or prevent these diseases.

AB - Mutations in a number of plasma proteins, including transthyretin, apolipoprotein AI, fibrinogen Aα-chain, lysozyme, and apolipoprotein AII, are associated with hereditary systemic amyloidosis. Transthyretin amyloidosis is the most common and is usually associated with peripheral neuropathy. Mutations in the other proteins usually have no neuropathic consequences and, instead, cause principally renal and cardiac amyloidosis. Only the apolipoprotein AI glycine 26 arginine mutation may cause peripheral neuropathy and then in only some of the kindreds with this disease. This review is concerned with the non-neuropathic hereditary systemic amyloidoses. It strives to present a synopsis of the present day knowledge of these diseases including each feature of each precursor protein and its mutations; the clinical phenotype of the disease; and suggestions for treatment when feasible. The main objective is to increase awareness of these autosomal dominant diseases, enhance the chances of early diagnosis, enhance the physician's and subsequently the patient's knowledge of each disease, and finally emphasize the need for more research to find ways to treat or prevent these diseases.

KW - Amyloid

KW - Amyloidosis

KW - Familial

KW - Hereditary

UR - http://www.scopus.com/inward/record.url?scp=22144469842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144469842&partnerID=8YFLogxK

U2 - 10.1080/13506120500106925

DO - 10.1080/13506120500106925

M3 - Article

VL - 12

SP - 75

EP - 87

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

IS - 2

ER -